Evaxion A (EVAX) Other Non Operating Income (2020 - 2025)
Evaxion A (EVAX) posted Other Non Operating Income of -$45000.0 for Q2 2025, down 287.5% on a QoQ basis from $24000.0 in Q2 2024, and down 287.5% year-over-year from $24000.0 in Q2 2024.
Evaxion A (EVAX) Other Non Operating Income (2020 - 2025) Analysis & Trends
Evaxion A's Other Non Operating Income history runs 6 years deep, the most recent figure standing at -$45000.0 for Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Evaxion A | 1.23 Bn | 1.23 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -45,000.00 |
| Jun 30, 2024 | 24,000.00 |
| Jun 30, 2023 | -9,000.00 |
| Jun 30, 2022 | -11,000.00 |
| Mar 31, 2022 | 18,000.00 |
| Sep 30, 2021 | -60,000.00 |
| Jun 30, 2021 | -57,000.00 |
| Mar 31, 2021 | 29,000.00 |
| Sep 30, 2020 | -6,000.00 |
| Jun 30, 2020 | -10,000.00 |